Hong Kong Drug Licence Applications and Acquisitions · RGYS|Global Licensing and Compliance Service Provider
Hong Kong pharmaceutical compliance · applications / acquisitions / ongoing maintenance Independent Third-Party Service Provider
HONG KONG DRUG LICENSING

I have seen people on social media selling prescription medicines supposedly “legitimately sourced from Hong Kong pharmacies”. Is this legal?

A complete explanation of the regulatory basis, Drew Tang’s recommendations and risk alerts. The original material dates from 2025; read it alongside the latest official requirements.

Original guide, 2025 edition: These FAQs are provided for topic-based reference and have not all been individually checked against current rules. Please confirm fees, personnel, renewal, changes and product requirements against the professional in-depth guide for the relevant licence type and the official requirements in force at the time.

Drug Office, Department of Health Chinese Medicines Board

Q419 · Category I: Renewals, changes and penalties for non-compliance (Q401-Q450)
This is absolutely illegal. In Hong Kong, all Part I poisons, particularly prescription medicines, must be sold to the patient or their representative in a registered pharmacy by a registered pharmacist or a pharmacist intern under their supervision, on the basis of a valid prescription issued by a registered medical practitioner in Hong Kong. Any sale without a prescription through social media, instant messaging software or a website, or by post or cross-border purchasing, bypasses this fundamental safety control mechanism and is unequivocally illegal. Sellers and organisers will face criminal prosecution.

📘 Regulatory basis

The Pharmacy and Poisons Ordinance (Cap. 138) imposes strict and explicit restrictions on the sale of prescription medicines, prohibiting any form of remote or unsupervised sale.

📗 Drew Tang's recommendations

As a licence holder, you are responsible for ensuring that your employees and business partners understand this legal red line. We recommend repeatedly emphasising in internal training that any employee involved in such grey-market transactions will be dismissed immediately and may be reported to the authorities.

📕 Risk notice

If your pharmacy is found to be the source of this kind of illegal parallel import, you may be held responsible for inadequate supervision even if you claim to have been unaware, and risk having your licence revoked. The Department of Health is stepping up its enforcement against such activities.

Back to Category I: Renewals, Changes and Penalties for Breaches (Q401-Q450) Search more questions

YOUR NEXT STEP

Plan Your Hong Kong Pharmaceutical Licensing Project with Drew Tang

Business Manager Tang Shangyong (Drew Tang) will review your products, operating model, licence type and preparation requirements with you one-to-one. The precise service scope is confirmed in writing; pharmaceutical duties are carried out by legally qualified personnel, and approvals are determined by the competent authorities.

Book a Project Assessment ↗